Drugs / Therapeutic vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT03525652 | Feb 2018 → Feb 2021 | prostate cancer | The First Affiliated Hospital of Guangdong Pharmaceutical University | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Therapeutic vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03525652 ↗ |
| Action | Activate | “activate the immune function to kill cancer cells” NCT03525652 ↗ |
| Modality | Vaccine | “therapeutic vaccine” NCT03525652 ↗ |